OptiBiotix Health Plc (LON:OPTI – Get Free Report) dropped 7.1% during mid-day trading on Wednesday . The stock traded as low as GBX 19.10 ($0.24) and last traded at GBX 19.50 ($0.25). Approximately 394,471 shares were traded during mid-day trading, an increase of 9% from the average daily volume of 361,810 shares. The stock had previously closed at GBX 21 ($0.27).
OptiBiotix Health Price Performance
The company has a market capitalization of £19.10 million, a P/E ratio of -650.00 and a beta of 1.71. The business’s 50-day moving average is GBX 14.32 and its two-hundred day moving average is GBX 18.09. The company has a quick ratio of 7.89, a current ratio of 6.18 and a debt-to-equity ratio of 4.51.
OptiBiotix Health Company Profile
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
Featured Stories
- Five stocks we like better than OptiBiotix Health
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 5 Top Rated Dividend Stocks to Consider
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
